Tandem Diabetes Care Inc (TNDM): Next-Year EPS Estimate 112.06%
As of 2026-06-04, Tandem Diabetes Care Inc (TNDM) has a next-year EPS growth estimate of 112.06%.
On 2026-05-31, analyst consensus for TNDM's next-year EPS growth shifted from 110.73% to 112.06% — a positive change of 1.33 percentage points. The revised estimate has been sustained across 5 subsequent trading sessions. Current-year growth is projected at 53.55%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Devices
- EPS growth next year
- 112.06%
- EPS growth this year
- 53.55%
- EPS next quarter (est)
- -$0.32
- Last price
- $19.45
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 112.06% | 53.55% | -$0.32 | $19.45 |
| 2026-06-03 | 112.06% | 53.55% | -$0.32 | $18.03 |
| 2026-06-02 | 112.06% | 53.55% | -$0.32 | $18.60 |
| 2026-06-01 | 112.06% | 53.55% | -$0.32 | $19.12 |
| 2026-05-31 | 112.06% | 53.55% | -$0.32 | $17.20 |
| 2026-05-28 | 110.73% | 53.74% | -$0.33 | $16.72 |
| 2026-05-27 | 110.73% | 53.74% | -$0.33 | $14.82 |
| 2026-05-26 | 111.15% | 53.83% | -$0.33 | $14.54 |
| 2026-05-25 | 111.15% | 53.83% | -$0.33 | $14.97 |
| 2026-05-24 | 111.15% | 53.83% | -$0.33 | $14.97 |
| 2026-05-21 | 111.15% | 53.83% | -$0.33 | $15.76 |
| 2026-05-20 | 111.15% | 53.83% | -$0.33 | $15.04 |
| 2026-05-19 | 111.15% | 53.83% | -$0.33 | $13.86 |
| 2026-05-18 | 111.15% | 53.83% | -$0.33 | $13.53 |
| 2026-05-17 | 111.15% | 53.83% | -$0.33 | $12.82 |
| 2026-05-14 | 111.15% | 53.83% | -$0.33 | $14.15 |
| 2026-05-13 | 110.95% | 53.84% | -$0.33 | $14.52 |
| 2026-05-12 | 110.99% | 53.34% | -$0.33 | $14.69 |
| 2026-05-11 | 110.50% | 53.53% | -$0.32 | $14.77 |
| 2026-05-10 | 110.47% | 53.59% | -$0.32 | $15.48 |
| 2026-05-07 | 103.52% | 47.58% | -$0.44 | $18.47 |
| 2026-05-06 | 103.52% | 47.58% | -$0.44 | $18.03 |
| 2026-05-05 | 103.52% | 47.58% | -$0.44 | $19.42 |
| 2026-05-04 | 103.52% | 47.58% | -$0.44 | $19.87 |
| 2026-05-03 | 105.73% | 48.08% | -$0.44 | $19.42 |
| 2026-04-30 | 105.73% | 48.08% | -$0.44 | $19.52 |
| 2026-04-29 | 105.73% | 48.08% | -$0.44 | $18.16 |
| 2026-04-28 | 105.73% | 48.08% | -$0.44 | $18.63 |
| 2026-04-27 | 105.73% | 48.08% | -$0.44 | $19.82 |
| 2026-04-26 | 105.73% | 48.08% | -$0.44 | $20.36 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Tandem Diabetes Care Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Tandem Diabetes Care Inc (TNDM) has a next-year EPS growth estimate of 112.06%, based on analyst consensus.
When was the latest EPS estimate revision for TNDM?▾
The most recent revision occurred on 2026-05-31, when analysts adjusted the next-year EPS growth estimate from 110.73% to 112.06%.
What sector and industry does Tandem Diabetes Care Inc belong to?▾
Tandem Diabetes Care Inc operates in the Healthcare sector, specifically the Medical Devices industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. TNDM appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Tandem Diabetes Care Inc (TNDM) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports